A phase I study of tasisulam sodium using an albumin-tailored dose in Japanese patients with advanced solid tumors.
Fujiwara Y, Ando Y, Mukohara T, Kiyota N, Chayahara N, Mitsuma A, Inada-Inoue M, Sawaki M, Ilaria R Jr, Kellie Turner P, Funai J, Maeda K, Minami H.
Fujiwara Y, et al. Among authors: mitsuma a.
Cancer Chemother Pharmacol. 2013 Apr;71(4):991-8. doi: 10.1007/s00280-013-2092-2. Epub 2013 Feb 1.
Cancer Chemother Pharmacol. 2013.
PMID: 23370664
Clinical Trial.